Morten Würtz

9PUBLICATIONS
38CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 30, 2026
Net clinical benefit of extended dual pathway inhibition in chronic coronary syndrome as classified by the 2024 ESC criteria: a COMPASS substudy.

Morten Würtz, Kevin Kris Warnakula Olesen, Qilong Yi

|Apr 16, 2025
Coronary Artery Disease Doubles Excess Mortality in Patients With Heart Failure With Reduced Ejection Fraction.

Nanna Anker, Kevin K W Olesen, Pernille G Thrane

|Apr 03, 2025
Myocardial Perfusion Imaging With PET: A Head-to-Head Comparison of 82Rubidium Versus 15O-water Tracers Using Invasive Coronary Measurements as Reference.

Simon Winther, Laust Dupont Rasmussen, Salma Raghad Karim

|Mar 07, 2024
Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy.

Morten Würtz, Kevin Kris Warnakula Olesen, Deepak L Bhatt

|Oct 21, 2022
Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation.

Thomas Jensen, Pernille G Thrane, Kevin K W Olesen

|Dec 06, 2021
Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score.

Morten Würtz, Kevin Kris Warnakula Olesen, Martin Bødtker Mortensen

Pageof 2

Frequent Collaborators

6 joint publications

Kevin Kris Warnakula Olesen

5 joint publications

Michael Maeng

4 joint publications

Martin Bødtker Mortensen

3 joint publications

John W Eikelboom